Phase I/II open-label trial of intravenous allogeneic mesenchymal stromal cell therapy in adults with recessive dystrophic epidermolysis bullosa - Rashidghamat, Ellie; Kadiyirire, Tendai; Ayis, Salma; Petrof, Gabriela; Liu, Lu; Pullabhatla, Venu; Ainali, Chrysanthi; Guy, Alyson; Aristodemou, Sophia; McMillan, James R.; Ozoemena, Linda; Mee, John; et al. (Journal of the American Academy of Dermatology, 2020)
Keywords: Adolescent; Adult; Aged; BM-MSC; epidermolysis bullosa; Epidermolysis Bullosa Dystrophica - complications; Epidermolysis Bullosa Dystrophica - diagnosis; Epidermolysis Bullosa Dystrophica - therapy; Female; Humans; Infusions, Intravenous; Male; Mesenchymal Stem Cell Transplantation - methods; mesenchymal stromal cells; Middle Aged; Prospective Studies; Pruritus - diagnosis; Pruritus - etiology; Pruritus - therapy; Quality of Life; RDEB; Severity of Illness Index; Transplantation, Homologous - methods; Treatment Outcome; Wound Healing; Young Adult; epidermolysis bullosa; CI; mesenchymal stromal cells; BM-MSC; RDEB; BM; SD; SCC; C7; SEM; MSC; EB; HMGB-1